Evidence map›Paper›PMID 31666379›Full record

ArticleJournal of virology2020

Cellular Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Mediates Nuclear Import of Human Bocavirus 1 NP1 Protein and Modulates Viral Capsid Protein Expression.

Xiaomei Wang, Peng Xu, Fang Cheng, Yi Li, Zekun Wang, Siyuan Hao, Jianke Wang, Kang Ning, Safder S Ganaie, John F Engelhardt and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Xiaomei WangSchool of Life Sciences and Technology, Wuhan University of Bioengineering, Wuhan, Hubei, China.
Peng XuSchool of Life Sciences and Technology, Wuhan University of Bioengineering, Wuhan, Hubei, China.
Fang ChengDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Yi LiSchool of Life Sciences and Technology, Wuhan University of Bioengineering, Wuhan, Hubei, China.
Zekun WangDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Siyuan HaoDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Jianke WangDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Kang NingDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Safder S GanaieDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID 0000-0002-9014-6577
John F EngelhardtDepartment of Anatomy and Cell Biology, University of Iowa, Iowa City, Iowa, USA.
Ziying YanDepartment of Anatomy and Cell Biology, University of Iowa, Iowa City, Iowa, USA.
Jianming QiuDepartment of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA jqiu@kumc.edu.
University of Kansas Medical Center · USWuhan University · CNUniversity of Iowa · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Vector CoreP01HL051670 · NHLBI · UNIVERSITY OF IOWA · PI MCCRAY, PAUL B · 1993 to 2019
$36.5M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
Molecular Regulation of Cell Development and Differentiation Phase III COBREP30GM122731 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ABRAHAMSON, DALE R · 2017 to 2021
$5.6M
Post-Transcriptional Regulation of Parvovirus Capsid Gene ExpressionR01AI070723 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI QIU, JIANMING · 2007 to 2017
$3.3M
Human bocavirus 1 (HBoV1) capsid entry and intracellular trafficking of polarized human airway epitheliumR21AI139572 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI QIU, JIANMING, YAN, ZIYING · 2018 to 2019
$434k
NHLBI NIH HHS P01 HL051670NIAID NIH HHS R01 AI070723NIAID NIH HHS R21 AI139572NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605NIGMS NIH HHS P30 GM122731
6 · The paper itself

Abstract

Human bocavirus 1 (HBoV1), which belongs to the genus

Indexed as

Cell NucleusGene Expression Regulation, ViralRNA, MessengerRNA, ViralActive Transport, Cell NucleusCapsid ProteinsHEK293 CellsHuman bocavirusHumansmRNA Cleavage and Polyadenylation FactorsMultiprotein ComplexesNuclear ProteinsRNA HelicasesCapsid Proteinscleavage factor Im, humanDHX15 protein, humanmRNA Cleavage and Polyadenylation FactorsMultiprotein ComplexesNuclear ProteinsRNA HelicasesRNA, MessengerRNA, ViralCPSF6DNA replicationhuman bocavirus 1mRNA processingNP1parvovirus

Identifiers

PMID31666379
PMCPMC6955249
OpenAlexW2981493496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.